Krilogy Financial LLC Purchases 1,789 Shares of Cigna Group $CI

Krilogy Financial LLC raised its position in shares of Cigna Group (NYSE:CIFree Report) by 51.0% during the 1st quarter, Holdings Channel reports. The fund owned 5,294 shares of the health services provider’s stock after purchasing an additional 1,789 shares during the period. Krilogy Financial LLC’s holdings in Cigna Group were worth $1,463,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC lifted its position in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Sivia Capital Partners LLC increased its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after buying an additional 109 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares in the last quarter. Treasurer of the State of North Carolina raised its position in shares of Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. bought a new position in shares of Cigna Group in the 2nd quarter valued at about $163,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Up 0.9%

Shares of NYSE CI opened at $281.92 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The firm has a 50-day simple moving average of $284.38 and a two-hundred day simple moving average of $278.71. The company has a market cap of $74.58 billion, a P/E ratio of 11.95, a PEG ratio of 1.08 and a beta of 0.28. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the prior year, the firm posted $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CI shares. Wolfe Research reissued an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st. Jefferies Financial Group decreased their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Guggenheim raised their price target on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Finally, Wells Fargo & Company lifted their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $338.30.

Read Our Latest Stock Report on Cigna Group

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.